The Association of Hereditary Prothrombotic Risk Factors with ST-Elevation Myocardial Infarction

İbrahim Halil Damar1, Recep Eroz2

  • 1Duzce University, Faculty of Medicine, Department of Cardiology, Duzce, Turkey.

Insights

Certain inherited thrombophilia gene variations are linked to ST-elevation myocardial infarction (STEMI). These genetic factors, including MTHFR A1298C and Factor XIII (V34L), may play a role in STEMI development and could inform future prevention strategies.

Area of Science:

  • Cardiovascular Genetics
  • Thrombophilia Research
  • Molecular Cardiology

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical manifestation of coronary artery disease, often linked to thrombotic events.
  • Understanding the genetic predispositions, particularly inherited thrombophilia, is crucial for identifying individuals at higher risk.

Purpose of the Study:

  • To investigate the association between various inherited thrombophilia gene variants and the occurrence of STEMI.
  • To compare the prevalence of these genetic factors in STEMI patients versus a control group.

Main Methods:

  • A case-control study involving 53 STEMI patients and 47 controls.
  • Genetic analysis of thrombophilia-associated genes including FactorV, MTHFR, FactorII, Factor XIII, PAI-1, and others.
  • Echocardiography and assessment of traditional cardiovascular risk factors.

Main Results:

  • Significant associations were found between STEMI and MTHFR A1298C, Factor XIII (V34L), ITGB, and ACE gene variations.
  • Specific gene variations showed increased prevalence in STEMI patients with comorbidities like smoking, hypertension, and family history of heart disease.

Conclusions:

  • Inherited thrombophilia gene variants are significantly associated with STEMI.
  • These genetic factors hold potential for the prevention and management of STEMI, warranting further investigation in larger cohorts.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
265
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
120
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
633
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
130
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
79
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
215